NEW
Replagal

Replagal Indications/Uses

Manufacturer:

Takeda

Distributor:

Zuellig
Full Prescribing Info
Indications/Uses
Replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry Disease (α-galactosidase A deficiency).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in